HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 40.00
+2.50 (6.67%)
Nov 13, 2026, 1:30 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.09 billion as of November 13, 2026. It is the 28,203rd most valuable company in the world and the 1,605th biggest in Taiwan. Its market cap has decreased by 25.68% in one year.
Market Cap
2.09B
Enterprise Value
1.27B
Revenue
305.13M
Global Rank
Country Rank
#1,605 Taiwan
PE Ratio
13.35
ChartMarket Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.09B, a decrease of -49.85%. That is a compound annual growth rate of -19.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.09B | -28.04% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.74B |
| Senhwa Biosciences | 2.65B |
| Energenesis Biomedical CO.,LTD. | 2.64B |
| Great Novel Therapeutics Biotech & Medicals | 2.49B |
| Chunghwa Chemical Synthesis & Biotech | 2.38B |
| GlycoNex Incorporation | 2.28B |
| Syngen Biotech | 2.18B |
| Taiwan Bio Therapeutics | 2.17B |